During the past decade, Toho University Omori Medical Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toho University Omori Medical Center" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Mitsubishi Tanabe Pharma America Inc." with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toho University Omori Medical Center" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eisai Co., Ltd." with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Toho University Omori Medical Center" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "ALS" (2 trials), "Coronary Artery Disease" (2 trials) and "Pyruvate Kinase Deficiency" (2 trials). Many other conditions were trialed in "Toho University Omori Medical Center" in a lesser frequency.

Most popular intervention types in "Toho University Omori Medical Center" are "Drug" (20 trials), "Device" (4 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Nintedanib" (4 trials), "MT-1186" (3 trials), "AG-348" (2 trials) and "Sildenafil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Toho University Omori Medical Center" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Toho University Omori Medical Center". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Toho University Omori Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Toho University Omori Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".